translate English to French: MHPD's clinical and scientific staff members review the AR reports, either as individual reports or as summary cumulative reports filed by industry, and then prioritize them based on risk. Working with the reports and other available evidence, staff may then determine the likelihood of a cause-and-effect relationship between the health product and reported ARs.
Le personnel clinique et scientifique de la DPSC examine les déclarations d'effets indésirables sous forme de rapports individuels ou de rapports cumulatifs sommaires présentés par l'industrie.